Skip to content
10-Q

Quarterly Report

PLIANT THERAPEUTICS, INC. PLRX

0001746473-25-000150

← back to feed
Filed
Aug 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 1, 2025 61.39M sh
Shares Diluted Q2 2025 · Jun 30, 2025 61.39M sh
Shares Diluted Q2 2025 · Jun 30, 2025 61.3M sh
Shares Diluted Q2 2025 · Jun 30, 2024 60.38M sh
Shares Diluted Q2 2025 · Jun 30, 2024 60.28M sh
Capex Q2 2025 · Jun 30, 2025 $374K
Capex Q2 2025 · Jun 30, 2024 $2.74M
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$89.47M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$75.57M
Long Term Debt Q2 2025 · Jun 30, 2025 $30.36M
Long Term Debt Q2 2025 · Dec 31, 2024 $30.21M
Short Term Investments Q2 2025 · Jun 30, 2025 $176.05M
Short Term Investments Q2 2025 · Dec 31, 2024 $284.54M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $86.82M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $71.19M
Stockholders Equity Q2 2025 · Jun 30, 2025 $220.08M
Stockholders Equity Q2 2025 · Mar 31, 2025 $257.16M
Stockholders Equity Q2 2025 · Dec 31, 2024 $304.08M
Stockholders Equity Q2 2025 · Jun 30, 2024 $392.68M
Stockholders Equity Q2 2025 · Mar 31, 2024 $437.33M
Stockholders Equity Q2 2025 · Dec 31, 2023 $473.58M
Current Liabilities Q2 2025 · Jun 30, 2025 $20.59M
Current Liabilities Q2 2025 · Dec 31, 2024 $33.22M
Total Liabilities Q2 2025 · Jun 30, 2025 $79.74M
Total Liabilities Q2 2025 · Dec 31, 2024 $92.87M
Current Assets Q2 2025 · Jun 30, 2025 $267.44M
Current Assets Q2 2025 · Dec 31, 2024 $362.26M
Total Assets Q2 2025 · Jun 30, 2025 $299.82M
Total Assets Q2 2025 · Dec 31, 2024 $396.95M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.71
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.62
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.92
Eps Diluted Q2 2025 · Jun 30, 2024 −$1.71
Eps Basic Q2 2025 · Jun 30, 2025 −$0.71
Eps Basic Q2 2025 · Jun 30, 2025 −$1.62
Eps Basic Q2 2025 · Jun 30, 2024 −$0.92
Eps Basic Q2 2025 · Jun 30, 2024 −$1.71
Sga Expense Q2 2025 · Jun 30, 2025 $13.39M
Sga Expense Q2 2025 · Jun 30, 2025 $28.89M
Sga Expense Q2 2025 · Jun 30, 2024 $15.02M
Sga Expense Q2 2025 · Jun 30, 2024 $30.27M
Rd Expense Q2 2025 · Jun 30, 2025 $32.2M
Rd Expense Q2 2025 · Jun 30, 2025 $75.63M
Rd Expense Q2 2025 · Jun 30, 2024 $45.62M
Rd Expense Q2 2025 · Jun 30, 2024 $82.76M
Net Income Q2 2025 · Jun 30, 2025 −$43.3M
Net Income Q2 2025 · Jun 30, 2025 −$99.47M
Net Income Q2 2025 · Mar 31, 2025 −$56.17M
Net Income Q2 2025 · Jun 30, 2024 −$55.85M
Net Income Q2 2025 · Jun 30, 2024 −$102.81M
Net Income Q2 2025 · Mar 31, 2024 −$46.96M
Operating Income Q2 2025 · Jun 30, 2025 −$45.59M
Operating Income Q2 2025 · Jun 30, 2025 −$104.53M
Operating Income Q2 2025 · Jun 30, 2024 −$60.64M
Operating Income Q2 2025 · Jun 30, 2024 −$113.03M